We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

32 hedge funds and large institutions have $6.14M invested in Acer Therapeutics Inc in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

497% more call options, than puts

Call options by funds: $203K | Put options by funds: $34K

177% more capital invested

Capital invested by funds: $2.22M → $6.14M (+$3.92M)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

14% more funds holding

Funds holding: 2832 (+4)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
7
Reduced
9
Closed
3
Calls
$203K
Puts
$34K
Net Calls
+$169K
Net Calls Change
+$109K

ACER Hedge Fund Activity: Q4 2022 in Review

32 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2022, worth a combined $6.14M — up 177% from $2.22M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ACER positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 9 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $909K. The largest seller was Citadel Advisors, cutting an estimated $88K.

  • 32 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2022, up from 28 in Q3 2022.
  • Funds reported $6.14M of Acer Therapeutics Inc stock for Q4 2022, up 177% quarter-over-quarter.
  • 7 funds opened new Acer Therapeutics Inc positions in Q4 2022 and 3 closed out, a net change of +4 holders.
  • The largest Acer Therapeutics Inc buyer in Q4 2022 was Nantahala Capital Management, an estimated $909K added.
  • The largest Acer Therapeutics Inc seller in Q4 2022 was Citadel Advisors, an estimated $88K sold.

Based on aggregated 13F filings for Q4 2022.